Psoriasis and Ayurveda: What a Pilot Study Reveals about Virechana and Phototherapy

Summary

Researchers conducted a pilot study to evaluate the combined effects of Virechana Karma and phototherapy in the treatment of psoriasis. Virechana, a purification therapy in Ayurveda, aims to eliminate toxins from the body, while phototherapy uses light to treat the skin. The study included a group of patients who received both interventions, resulting in significant improvements in psoriasis severity, measured by clinical scales. The authors, Dr. Preeti Chaturvedi and Dr. Suwarna Suryawanshi, observed that the combination of these approaches not only reduced skin lesions but also improved the quality of life of participants. Although the study has a limited number of participants and is a pilot, the results suggest that integrating Ayurvedic practices with modern therapies may offer a new path for managing psoriasis.

Key points

Virechana Karma promotes the elimination of toxins, enhancing the response to treatment.
Phototherapy has demonstrated efficacy in reducing psoriatic lesions in several studies.
The combination of the two approaches resulted in significant improvements in psoriasis severity.
The study is a pilot, with limitations in terms of number of participants and duration of follow-up.
The integration of Ayurveda and modern therapies may open new possibilities in the treatment of psoriasis.

✦ For you

If you live with psoriasis, consider observing how your skin reacts to different treatments and self-care routines. The practice of purification techniques, such as Virechana, may be an option to explore, but always under the guidance of a qualified healthcare professional. Keep a symptom diary to identify patterns and triggers.

For practitionersExpand

When considering the treatment of psoriasis, evaluate the possibility of integrating Virechana Karma with phototherapy in your practice. The combination may enhance results, especially in patients who do not respond adequately to isolated treatments. This pilot study suggests a promising path, but it is important to monitor each patient's individual response.